SCA
VRTX icon

Stonebridge Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Stonebridge Capital Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-121
Closed -$42.1K – 844
2023
Q3 		$42.1K Hold
121
– – ﹤0.01% 383
2023
Q2 		$42.6K Buy
+121
New +$40.8K ﹤0.01% 393
2023
Q1 		– Sell
-32
Closed -$9.24K – 1008
2022
Q4 		$9.24K Sell
32
-1
-3% -$305 ﹤0.01% 610
2022
Q3 		$10K Sell
33
-94
-74% -$27K ﹤0.01% 581
2022
Q2 		$36K Hold
127
– – ﹤0.01% 402
2022
Q1 		$33K Hold
127
– – ﹤0.01% 453
2021
Q4 		$28K Hold
127
– – ﹤0.01% 458
2021
Q3 		$23K Hold
127
– – ﹤0.01% 468
2021
Q2 		$26K Buy
+127
New +$26.6K ﹤0.01% 580
2020
Q1 		– Sell
-9
Closed -$2K – 865
2019
Q4 		$2K Buy
+9
New +$1.82K ﹤0.01% 756

Other funds holding VRTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return